Clinical Trial

Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women

Study acronym: WB2020
Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Aging is the primary risk factor for CVD, in large part due to adverse modifications to the arteries. These modifications include vascular endothelial dysfunction and arterial stiffness. Vascular endothelial dysfunction is an initiating step in atherosclerosis, and is primarily caused by reduced nitric oxide (NO) bioavailability secondary to excessive superoxide-driven oxidative stress and inflammation. Endothelial dysfunction leads to arterial stiffness and the development of hypertension (HTN) which further increases CVD. Greater than 2/3 of the US population has elevated blood pressure or stage 1-HTN. As such, interventions that improve vascular endothelial dysfunction by increasing NO bioavailability and mitigating excessive oxidative stress and inflammation are needed. Blueberries are rich in bioactive compounds including flavonoids, phenolic acids, and pterostilbene. These compounds and their metabolites have been shown to attenuate oxidative stress and inflammation. The primary goal of this study is to assess the efficacy of blueberries to improve reduce blood pressure and improve vascular endothelial dysfunction and arterial stiffness in middle-aged/older men with elevated blood pressure or stage 1-HTN.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-08-25; most recent amendment 2025-11-13.
Status change: Recruiting → Active, Not Recruiting 2025-11-13
Trial Details
NCT Number NCT04530916
Lead Sponsor Colorado State University
Collaborators: Wild Blueberry Association of North America
Conditions Hypertension, Aging, Endothelial Dysfunction, Men
Enrollment 58 participants
Start Date 2020-01-01
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-17